Cargando…

Nanomedicines and Nanosimilars—Why a Robust Centralised Regulatory Framework Is Essential to Enhance Patient Safety

Detalles Bibliográficos
Autor principal:	Isles, Michael P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907565/ https://www.ncbi.nlm.nih.gov/pubmed/35280250 http://dx.doi.org/10.3389/fphar.2021.787239

Ejemplares similares

Medication practice in hospitals: are nanosimilars evaluated and substituted correctly?
por: Knoeff, Josefien, et al.
Publicado: (2018)

Differences in Physico-Chemical Properties and Immunological Response in Nanosimilar Complex Drugs: The Case of Liposomal Doxorubicin
por: Lipsa, Dorelia, et al.
Publicado: (2023)

Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery
por: Zhang, Bo, et al.
Publicado: (2017)

The Centralisation of Energy
por: Wooton, Edwin
Publicado: (1880)

Inconsistent centralised versus non-centralised ischaemic stroke aetiology
por: Suo, Yue, et al.
Publicado: (2020)

Editorial: Women in nanomedicine
por: Chuah, Lay-Hong, et al.
Publicado: (2023)

Editorial: Advances and Challenges in Nanomedicine
por: Hua, Susan, et al.
Publicado: (2018)

Activation of cancer immunotherapy by nanomedicine
por: Wang, Lijuan, et al.
Publicado: (2022)

Hospital Centralisation at Aberdeen
Publicado: (1887)

A centralised approach
por: Mannan, K. A. A.
Publicado: (2020)

Ferroptosis-Inducing Nanomedicine for Cancer Therapy
por: Wang, Yang, et al.
Publicado: (2021)

Application Perspectives of Nanomedicine in Cancer Treatment
por: Hou, Shanshan, et al.
Publicado: (2022)

Editorial: Advances on targeted nanomedicines for atherosclerosis
por: Han, Qinggong, et al.
Publicado: (2022)

Functional Nanomedicines for Targeted Therapy of Bladder Cancer
por: Tang, Chao, et al.
Publicado: (2021)

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
por: Hu, Ping Ping, et al.
Publicado: (2022)

Editorial: Translating nanomedicines for anti-cancer treatment
por: Siram, Karthik, et al.
Publicado: (2023)

Centralisation of ROOT Help Systems
por: Khairallah, Elie
Publicado: (2018)

Advancing herbal medicine: enhancing product quality and safety through robust quality control practices
por: Wang, Hongting, et al.
Publicado: (2023)

Editorial: Nanomedicine in Infectious Diseases: Drug Delivery and Vaccines
por: Marepally, Srujan, et al.
Publicado: (2022)

Pharmacologic therapies of ARDS: From natural herb to nanomedicine
por: Meng, Linlin, et al.
Publicado: (2022)

Discovery of Selenocysteine as a Potential Nanomedicine Promotes Cartilage Regeneration With Enhanced Immune Response by Text Mining and Biomedical Databases
por: Ye, Jing, et al.
Publicado: (2020)

Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
por: He, Lili, et al.
Publicado: (2016)

The Potential of Chitosan in Nanomedicine: An Overview of the Cytotoxicity of Chitosan Based Nanoparticles
por: Frigaard, Julie, et al.
Publicado: (2022)

Will nanomedicine become a good solution for the cardiotoxicity of chemotherapy drugs?
por: Jiang, Yichuan, et al.
Publicado: (2023)

Centralised treatment, entry to trials and survival.
por: Stiller, C. A.
Publicado: (1994)

Hospital Libraries: A Scheme for Centralisation
Publicado: (1919)

What drives centralisation in cancer care?
por: Kilsdonk, Melvin J., et al.
Publicado: (2018)

Intracellular Reduction-Responsive Molecular Targeted Nanomedicine for Hepatocellular Carcinoma Therapy
por: Ding, Lei, et al.
Publicado: (2022)

Two-Dimensional Nanosheet-Based Photonic Nanomedicine for Combined Gene and Photothermal Therapy
por: Kim, Na Yoon, et al.
Publicado: (2020)

Mesenchymal Stem Cell–Derived Exosomes: A Promising Biological Tool in Nanomedicine
por: Wei, Wumei, et al.
Publicado: (2021)

Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
por: Li, Xue, et al.
Publicado: (2022)

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies
por: Yang, Fan, et al.
Publicado: (2023)

Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States
por: Iglesias-Lopez, Carolina, et al.
Publicado: (2019)

Anomaly Detection for the Centralised Elasticsearch Service at CERN
por: Andersson, Jennifer R, et al.
Publicado: (2021)

Centralisation versus Decentralisation: How to Fight Tuberculosis
Publicado: (1917)

Anomaly Detection for the Centralised Elasticsearch Service at CERN
por: Andersson, Jennifer R., et al.
Publicado: (2021)

Free Field Realisation of the Chiral Universal Centraliser
por: Beem, Christopher, et al.
Publicado: (2023)

The need for robust characterization of nanomaterials for nanomedicine applications
por: Mahmoudi, Morteza
Publicado: (2021)

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
por: Hua, Susan, et al.
Publicado: (2018)

Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy
por: Zhang, Jinlan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p3sbm05dhdopejrhvupe0a7dud